Medical Instrument & Supply Manufacturing in European Union 2026: Industry Statistics & Trends

The medical instrument and supply manufacturing industry in the European Union involves the production of laboratory apparatus, surgical equipment, orthopedic appliances, and diagnostic tools. According to official sector data from MedTech Europe, the European medical technology market reached an estimated value of €170 billion in 2024, making it the second-largest market globally. The industry is highly innovative and productive, with Eurostat and European Patent Office figures showing more than 15,700 medical technology patent applications filed in 2024, representing 7.9% of all European patent applications.

Industry snapshot

Key public data points

Historical & forecast

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.

What does the Medical Instrument & Supply Manufacturing in European Union industry cover?

This industry encompasses the development, manufacturing, and distribution of physical apparatuses utilized in medical, dental, veterinary, and laboratory procedures. The scope covers everything from low-tech consumables like syringes, bandages, and surgical drapes to complex medical machinery, pacemakers, and orthopedic prosthetics. It excludes basic pharmaceuticals and biotechnology products, focusing strictly on medical devices, in-vitro diagnostics, and specialized medical furniture.

• •The sector corresponds to the official European Union economic classification NACE Rev. 2 code 32.50 (Manufacture of medical and dental instruments and supplies).
• •It spans over 15 distinct product categories, which range from diagnostic imaging and wound management to ophthalmic devices and cardiovascular implants.
• •In vitro diagnostics (IVDs) represent the largest single product family within the broader European medical technology framework.

Who operates in the industry and how is it structured?

The European market is heavily decentralized and characterized by a vast network of highly specialized small and medium-sized enterprises (SMEs). These smaller operators drive local manufacturing hubs and custom medical product development, often acting as subcontractors for larger corporations. Multinationals maintain massive distribution centers and highly sophisticated manufacturing sites in key geographic clusters, particularly in Germany, Ireland, and France.

• •There are approximately 38,000 medical technology business entities operating across Europe, according to MedTech Europe 2025 data.
• •Small and medium-sized enterprises (SMEs) make up roughly 90% of all registered companies in the industry.
• •The sector is a powerful source of employment, directly employing more than 930,000 people across the region as of 2024/2025.

What drives demand in the industry?

The fundamental driver of demand in the EU is an aging demographic profile paired with an increasing prevalence of chronic, long-term diseases such as diabetes and cardiovascular conditions. This shift requires sustained investment in diagnostic equipment, orthopedic implants, and long-term care supplies. Furthermore, European national healthcare systems are actively funding digital healthcare infrastructure and remote patient monitoring to alleviate pressure on hospital resources.

• •Germany and France expanded structural reimbursement pathways for digital health applications (such as Germany's DiGA) to incentivize the integration of digital therapeutics.
• •Belgium launched its official national reimbursement framework for mobile health (m-health) solutions in January 2025.
• •National healthcare expenditures across the EU vary significantly, typically ranging from 5% to 12% of total GDP.

Who are the notable companies in the industry?

Competition in the European Union is intense, characterized by a mix of home-grown European industrial giants and global multinationals with deep-rooted manufacturing footprints in Europe. These firms compete on product efficacy, regulatory speed-to-market, and integration with digital health software. Market leadership is sustained by intense research and development cycles and high capital investment in manufacturing automation.

• •Siemens Healthineers AG (Germany) is a leading global operator in diagnostic imaging and advanced therapies.
• •Philips NV (Netherlands) focuses heavily on image-guided therapy, ultrasound technology, and monitoring systems.
• •EssilorLuxottica SA (France) represents a major force in the manufacturing of ophthalmic devices, lenses, and optical equipment.
• •Smith & Nephew plc (UK/Europe) is highly active in the EU market for orthopedic reconstruction, sports medicine, and advanced wound management.

What are the recent trends and outlook?

The industry is experiencing a rapid transition toward digital health, artificial intelligence integration, and sustainable circular manufacturing practices. Manufacturers are investing heavily in reducing their carbon footprints by utilizing eco-designed materials and optimizing clinical supply chains. High productivity levels keep the industry economically resilient despite overall manufacturing slowdowns in the wider European Union economy.

• •The value added per employee in the European medical technology industry is estimated at approximately €183,000, signaling high productivity.
• •Patent activity remains exceptionally high, with 15,701 medical technology patent applications filed with the European Patent Office in 2024.
• •The EU maintained a positive trade balance of €5 billion in medical devices in 2024.

How is the industry regulated?

EU manufacturers operate under some of the most rigorous regulatory frameworks in the world, primarily designed to guarantee clinical safety and performance. Compliance is governed by strict, harmonized rules that require extensive clinical evidence and third-party conformity assessments. The transition to these updated legal frameworks has significantly impacted product portfolios, timeline projections, and supply chain strategies for both local SMEs and global players.

• •The industry is strictly regulated by the European Union Medical Device Regulation (MDR) (Regulation (EU) 2017/745).
• •In vitro diagnostic manufacturers are subject to the stringent rules of the In Vitro Diagnostic Regulation (IVDR) (Regulation (EU) 2017/746).
• •Unique Device Identification (UDI) compliance deadlines continue to phase in across Europe to improve traceability and post-market safety surveillance.

Government, statistical and trade sources used for this Claight analysis.

• MedTech Europe Facts & Figures 2025 ·
• European Patent Office (EPO) Annual Report 2024 ·
• Eurostat NACE Rev. 2 Classification Database ·
• European Commission Medical Devices Regulations (MDR/IVDR)